- Stock: Out Of Stock
- Model: B7-33 2mg
- Molecular Formula: B7-23
- Research use only: Yes
B7-33 exhibits potent anti-fibrotic effects. It is under active research and investigation to reduce fibrosis in acute and chronic diseases like heart failure, lung inflammation, kidney, and more.
In animal studies, B7-33 has reduced fibrosis by roughly 50%, leading to prolonged survival following injury and offering the first new means of treating heart failure in 20 years.
It has been shown to reduce excessive scar formation following cardiac injury. It has also shown promise in the treatment of certain vascular disorders and preeclampsia of pregnancy.
|Physical and chemical properties|
|Physical Appearance||white lyophilised solid|
|Form & Formulations||Sterile filtered white lyophilized (freeze-dried)|
|Storage||Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18°C. Upon reconstitution of the peptide it should be stored at 4°C between 2-21 days and for future use below -18°C.|
|HPLC||Shows min 99% Purity|
|Mass Spectrum||Consistent with structure|
|Caution||Research use only / Not for human or veterinary use|
All products listed and supplied by UK Peptides are strictly for research purposes only. We neither advocate nor support the personal usage of these products.
Products offered by UK Peptides are not intended for inclusion in food items or to be used as any form of medication. Our products are not designed to treat, prevent, lessen or cure any health condition or disease; they are solely for research purposes.
Please remember improper usage of these products can be harmful. Therefore, professionals must handle our products in a controlled environment for scientific research and study.